| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $621.3M | +3.2% |
| R&D Expense | $16.5M | -26.1% |
| SG&A Expense | $123.4M | +10.1% |
| Operating Income | -$182.6M | +34.3% |
| Pre-tax Income | -$226.1M | +23.8% |
| Income Tax | -$2.0M | -115.0% |
| Net Income | -$224.1M | +24.2% |
| EPS (Basic) | -$20.69 | +23.5% |
| EPS (Diluted) | -$20.69 | +23.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.8M | -78.3% |
| Accounts Receivable | $13.9M | +74.0% |
| Current Assets | $99.8M | -38.1% |
| Total Assets | $1.14B | -25.2% |
| Current Liabilities | $338.5M | -33.1% |
| Long-term Debt | $218.2M | +28.2% |
| Total Liabilities | $1.57B | -17.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$129.2M | -16.5% |
| Capital Expenditures | $3.1M | -70.6% |
| Investing Cash Flow | $5.7M | +146.3% |
| Financing Cash Flow | $59.9M | +285.7% |
| Free Cash Flow | -$132.3M | -8.9% |
| Stockholders' Equity |
| -$598.8M |
| -59.0% |